ATE125704T1 - Behandlung neurodegenerativer erkrankungen. - Google Patents

Behandlung neurodegenerativer erkrankungen.

Info

Publication number
ATE125704T1
ATE125704T1 AT93303746T AT93303746T ATE125704T1 AT E125704 T1 ATE125704 T1 AT E125704T1 AT 93303746 T AT93303746 T AT 93303746T AT 93303746 T AT93303746 T AT 93303746T AT E125704 T1 ATE125704 T1 AT E125704T1
Authority
AT
Austria
Prior art keywords
neurodegenerative diseases
treatment
pseudooxynicotine
administering
treated
Prior art date
Application number
AT93303746T
Other languages
English (en)
Inventor
William S Caldwell
Patrick M Lippiello
Original Assignee
Reynolds Tobacco Co R
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Reynolds Tobacco Co R filed Critical Reynolds Tobacco Co R
Application granted granted Critical
Publication of ATE125704T1 publication Critical patent/ATE125704T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pyridine Compounds (AREA)
AT93303746T 1992-05-21 1993-05-14 Behandlung neurodegenerativer erkrankungen. ATE125704T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/887,192 US5232932A (en) 1992-05-21 1992-05-21 Method for treatment of neurodegenerative diseases

Publications (1)

Publication Number Publication Date
ATE125704T1 true ATE125704T1 (de) 1995-08-15

Family

ID=25390643

Family Applications (1)

Application Number Title Priority Date Filing Date
AT93303746T ATE125704T1 (de) 1992-05-21 1993-05-14 Behandlung neurodegenerativer erkrankungen.

Country Status (5)

Country Link
US (1) US5232932A (de)
EP (1) EP0571139B1 (de)
JP (1) JPH0632735A (de)
AT (1) ATE125704T1 (de)
DE (1) DE69300321T2 (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5977144A (en) * 1992-08-31 1999-11-02 University Of Florida Methods of use and compositions for benzylidene- and cinnamylidene-anabaseines
US5852041A (en) * 1993-04-07 1998-12-22 Sibia Neurosciences, Inc. Substituted pyridines useful as modulators of acethylcholine receptors
US5585388A (en) * 1995-04-07 1996-12-17 Sibia Neurosciences, Inc. Substituted pyridines useful as modulators of acetylcholine receptors
US5794887A (en) 1995-11-17 1998-08-18 Komerath; Narayanan M. Stagnation point vortex controller
KR20010052171A (ko) 1998-04-02 2001-06-25 알. 제이. 레이놀즈 터베코 컴퍼니 의약 조성물 및 그 사용방법
US6232316B1 (en) 1998-06-16 2001-05-15 Targacept, Inc. Methods for treatment of CNS disorders
US20010031771A1 (en) 1999-05-24 2001-10-18 Gary Maurice Dull Pharmaceutical compositions and methods for use
US6455554B1 (en) 1999-06-07 2002-09-24 Targacept, Inc. Oxopyridinyl pharmaceutical compositions and methods for use
AU5326100A (en) * 1999-06-07 2000-12-28 Targacept, Inc. Pharmaceutical compositions and methods for use
CA2494506C (en) * 2002-08-02 2009-02-10 Nutraceutical Development Corporation Development of muscle mass in a mammal
WO2007018072A1 (ja) 2005-08-08 2007-02-15 Ntn Corporation センサ付車輪用軸受
JP5019988B2 (ja) 2007-07-31 2012-09-05 Ｎｔｎ株式会社 センサ付車輪用軸受
EP2184182B1 (de) 2007-07-31 2016-11-02 NTN Corporation Mit sensor ausgestattetes radlager
EP2708865B1 (de) 2011-05-09 2019-09-04 NTN Corporation Mit einem sensor ausgestattetes radlager

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3870794A (en) * 1974-02-20 1975-03-11 Foundation For Behavioral Rese Treatment of certain emotional disorders with nicotine compounds
HU179164B (en) * 1979-12-14 1982-08-28 Egyt Gyogyszervegyeszeti Gyar Process for producing cycloalkyl-ethers of alkanolamines
US4442292A (en) * 1981-01-29 1984-04-10 Philip Morris Incorporated Optically active nicotine analogs and process for their preparation
US4578394A (en) * 1984-12-10 1986-03-25 Hoechst-Roussel Pharmaceuticals Incorporated Cholinergic function increasing 3-[N-(pyridyl) carbamoyl]-1,4-dihydropyridines
US4965074A (en) * 1985-03-05 1990-10-23 Ciba-Geigy Corporation Method of treating memory impairment
US4765985A (en) * 1985-03-05 1988-08-23 Ciba-Geigy Corporation Devices and methods for treating memory impairment
US4863930A (en) * 1986-12-19 1989-09-05 Adhikary Parimal K Use of substituted 5H-pyrido- and 5H-thiazolo(2',1':2,3)imidazo (4,5-b)indoles as cholinomimetic agents
IE63906B1 (en) * 1987-11-13 1995-06-14 Novo Nordisk As Azabicyclic compounds and their preparation and use
IE62662B1 (en) * 1989-01-06 1995-02-22 Elan Corp Plc Use of nicotine in the treatment of conditions susceptible to said treatment
US5015741A (en) * 1989-10-03 1991-05-14 Philip Morris Incorporated Nicotine analogs

Also Published As

Publication number Publication date
DE69300321T2 (de) 1996-02-29
EP0571139B1 (de) 1995-08-02
US5232932A (en) 1993-08-03
DE69300321D1 (de) 1995-09-07
JPH0632735A (ja) 1994-02-08
EP0571139A1 (de) 1993-11-24

Similar Documents

Publication Publication Date Title
DE69304955D1 (de) Behandlung von neurodegenerativen Erkrankungen
DE69523350D1 (de) Behandlung von hyperproliferativen Gefässerkrankungen
ATE144898T1 (de) Behandlung neurodegenerativer krankheiten
DE69300321D1 (de) Behandlung neurodegenerativer Erkrankungen.
DE69736441D1 (de) Pharmazeutische zusammensetzung zur behandlung von neurologischen und neuropsychiatrischen erkrankungen
NO20101190L (no) Anvendelse av buprenorfin i fremstillingen av et medikament
DE69739142D1 (de) Pharmazeutische zusammenstellungen zur prävention und behandlung von zns-erkrankungen
ATE116550T1 (de) Behandlung von neoplastischen krankenheiten mit interleukin-10.
ATE137116T1 (de) Behandlung von entzündlichen erkrankungen mit 15- ketoprostaglandinen
KR950010156B1 (en) Pharmaceutical dosage unit for the prevention or treatment of climacteric complaints
DE69303234D1 (de) Behandlung von entzündlichen Darmerkrankungen
ATE180669T1 (de) Verwendung von pregnanderivaten zur behandlung von tumoren
ATE239470T1 (de) Melatonin-derivate zur verwendung in der behandlung von desynchronisierungs-erkankungen
DE69313261T2 (de) Verwendung von LACTOFERRIN zur Herstellung eines THERAPEUTISCHEN MITTELS zur Behandlung von RHEUMATISMUS
DE69419954D1 (de) Arzneimittel zur Behandlung von Hauterkrankungen
ES1022449Y (es) Aparato terapeutica para tratamiento de sintomas ocasionados por enfermedades.
EE03437B1 (et) Benseenamiidid neurodegeneratiivsete haiguste ravimiseks
DE69924979D1 (de) Behandlung von chronischen schmerzen
ATE302011T1 (de) PONAZURIL ZUR BEHANDLUNG VON DURCH COCCIDIA NEUROLOGISCHEN UND ßABORTIGENICß VERURSACHTEN ERKRANKUNGEN
ATE149840T1 (de) Behandlung von leberkrebs
DE69124415D1 (de) Verwendung von 15-Dehydroxy-16-Oxoprostaglandin bei der Behandlung von allergischen Erkrankungen
ATE167398T1 (de) Behandlungsverfahren für therapiewiderstehende schizophrenie mit amperozide
ATE146964T1 (de) Behandlung von katarakt mit prostacyclinverbindungen
DE59609219D1 (de) Verwendung von 1-hydroxy-2-pyridonen zur behandlung von schwer therapierbaren schleimhauterkrankungen
ATE336282T1 (de) Katheter zur behandlung von prostaterkrankungen

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties